Key result
Metabolic dysregulation in T2DM linked to higher subcortical iron susceptibility, which partially mediates cognitive decline.
Why the study?
Research on brain iron deposition in T2DM remains scarce, with few studies directly linking iron accumulation in cognition-related subcortical nuclei to cognitive dysfunction.
Is Type 2 diabetes mellitus associated with increased brain iron deposition and cognitive dysfunction compared to healthy controls?
Cohort (n=224)
Is Type 2 diabetes mellitus associated with increased brain iron deposition and cognitive dysfunction compared to healthy controls?
Effect estimate: β = 0.224
p-value: p=0.010
T2DM is associated with increased iron deposition in the caudate and putamen, which partially mediates T2DM-induced cognitive impairment.
Iron may mediate T2DM cognitive decline; leaves open causality and need for prospective confirmation.
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly impacts cognitive health. Although the vascular complications of T2DM have been extensively studied, research on brain iron deposition in T2DM remains scarce, and few studies have directly linked iron accumulation in cognition-related subcortical nuclei to cognitive dysfunction. This study aims to evaluate brain iron deposition using quantitative susceptibility mapping (QSM) and identify key subcortical nuclei associated with T2DM-related cognitive decline. A total of 224 participants were recruited, including 112 T2DM patients and 112 healthy controls. QSM was used to assess iron deposition in subcortical nuclei. Structural equation modeling was employed to construct interaction models between metabolic changes, susceptibility values, and cognitive function. Additionally, polynomial regression analysis was performed to evaluate the association between glycemic variability and the QSM values of subcortical nuclei. Our findings confirmed that T2DM patients exhibited pronounced iron deposition in the caudate and putamen compared to healthy controls. Correlation analyses showed that higher QSM values in the anterior putamen, posterior putamen, and posterior caudate were associated with slower processing speed (SDMT), reduced memory performance (AVLT) and poorer executive function (TMT, SCWT), indicating that greater iron accumulation in these nuclei is associated with poorer cognitive performance. In our SEM, metabolic dysregulation was significantly associated with higher subcortical susceptibility (β = 0.224, p = 0.010). The model further demonstrated that susceptibility values partially mediated the effect of metabolic factors on cognition (indirect effect β = -0.056, p = 0.018) and that the overall impact of metabolic dysregulation on cognition remained significant (β = -0.142, p = 0.037). Polynomial regression found that HbA1c was the strongest predictor of anterior putamen susceptibility, and a similar pattern was observed in the posterior caudate. The study demonstrates that the role of brain iron deposition in T2DM-related cognitive dysfunction. These findings reveal an important underlying mechanism of T2DM-induced cognitive impairment and provide evidence for early intervention strategies to mitigate cognitive decline in T2DM patients.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) conducted a cohort in Type 2 diabetes mellitus (T2DM) (n=224). Type 2 diabetes mellitus vs. Healthy controls was evaluated on Association between metabolic dysregulation and subcortical susceptibility (β = 0.224, p=0.010). Metabolic dysregulation in T2DM was significantly associated with higher subcortical iron susceptibility (β = 0.224, p = 0.010), which partially mediated cognitive decline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: